Page last updated: 2024-09-03

cgs 22652 and ridogrel

cgs 22652 has been researched along with ridogrel in 2 studies

Compound Research Comparison

Studies (cgs 22652)	Trials (cgs 22652)	Recent Studies (post-2010) (cgs 22652)	Studies (ridogrel)	Trials (ridogrel)	Recent Studies (post-2010) (ridogrel)
10	0	0	90	10	1

Protein Interaction Comparison

Protein	Taxonomy	ridogrel (IC50)
Thromboxane A2 receptor	Homo sapiens (human)	2.48
Thromboxane-A synthase	Homo sapiens (human)	0.0062
Thromboxane-A synthase	Rattus norvegicus (Norway rat)	0.006

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bhagwat, SS; Boswell, C; Cohen, DS; Contardo, N; Dotson, R; Furness, P; Gude, C; Lee, W; Mathis, J; Zoganas, H	1
Eisert, W; Heckel, A; Müller, TH; Nickl, J; Soyka, R; Weisenberger, H	1

Other Studies

2 other study(ies) available for cgs 22652 and ridogrel

Article	Year
Thromboxane receptor antagonism combined with thromboxane synthase inhibition. 4. 8-[[(4-Chlorophenyl)sulfonyl]amino]-4-(3-(3-pyridinyl) propyl)octanoic acid and analogs. Journal of medicinal chemistry, 1992, Nov-13, Volume: 35, Issue:23 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Bronchoconstriction; Caprylates; Dogs; Guinea Pigs; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Pyridines; Receptors, Thromboxane; Structure-Activity Relationship; Sulfonamides; Thromboxane-A Synthase; Vasoconstrictor Agents	1992
6,6-Disubstituted Hex-5-enoic acid derivatives as combined thromboxane A2 receptor antagonists and synthetase inhibitors. Journal of medicinal chemistry, 1994, Jan-07, Volume: 37, Issue:1 Topics: Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Collagen; Drug Design; Fatty Acids, Unsaturated; Humans; Hydrazines; Molecular Conformation; Molecular Structure; Phosphodiesterase Inhibitors; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyridines; Receptors, Thromboxane; Structure-Activity Relationship; Thromboxane A2; Thromboxane-A Synthase; Tritium	1994

Article

Year

Thromboxane receptor antagonism combined with thromboxane synthase inhibition. 4. 8-[[(4-Chlorophenyl)sulfonyl]amino]-4-(3-(3-pyridinyl) propyl)octanoic acid and analogs.

Journal of medicinal chemistry, 1992, Nov-13, Volume: 35, Issue:23

Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Bronchoconstriction; Caprylates; Dogs; Guinea Pigs; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Pyridines; Receptors, Thromboxane; Structure-Activity Relationship; Sulfonamides; Thromboxane-A Synthase; Vasoconstrictor Agents

1992

6,6-Disubstituted Hex-5-enoic acid derivatives as combined thromboxane A2 receptor antagonists and synthetase inhibitors.

Journal of medicinal chemistry, 1994, Jan-07, Volume: 37, Issue:1

Topics: Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Collagen; Drug Design; Fatty Acids, Unsaturated; Humans; Hydrazines; Molecular Conformation; Molecular Structure; Phosphodiesterase Inhibitors; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyridines; Receptors, Thromboxane; Structure-Activity Relationship; Thromboxane A2; Thromboxane-A Synthase; Tritium

1994